However, tesofensine faces significant challenges - cardiovascular side effects (increased heart rate and blood pressure) raised safety concerns, FDA has not approved it despite promising efficacy data, development stalled after Phase 3 trials, currently available only through research chemical suppliers with questionable legality, and the stimulant-like mechanism creates dependency and tolerance risks not seen with GLP-1 agonists
A comprehensive review of amyotrophic lateral sclerosis
Thoughtful monitoring, early symptom reporting, and individualized plans help keep therapy safe
"We are in a whole new world
By the summer of 1921, they had managed to extract insulin which they injected into a diabetic dog, restoring its health
Conquer brawny with generous bonuses and munificent spins